QCM
WST icon

Quantinno Capital Management’s West Pharmaceutical WST Stock Holding History

Quantinno Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Buy
308,116
+146,638
+91% +$44.8M 0.13% 137
2026
Q1 		$40.5M Buy
161,478
+56,072
+53% +$14M 0.07% 349
2025
Q4 		$29M Buy
105,406
+13,080
+14% +$3.58M 0.06% 390
2025
Q3 		$24.2M Buy
92,326
+52,890
+134% +$12.9M 0.07% 351
2025
Q2 		$8.63M Buy
39,436
+28,359
+256% +$6.06M 0.04% 591
2025
Q1 		$2.48M Buy
11,077
+4,942
+81% +$1.36M 0.02% 910
2024
Q4 		$2.01M Buy
6,135
+2,297
+60% +$723K 0.02% 847
2024
Q3 		$1.15M Buy
3,838
+1,573
+69% +$482K 0.02% 906
2024
Q2 		$746K Buy
2,265
+344
+18% +$122K 0.01% 910
2024
Q1 		$760K Buy
1,921
+249
+15% +$92.1K 0.02% 827
2023
Q4 		$589K Sell
1,672
-252
-13% -$89.2K 0.02% 775
2023
Q3 		$722K Buy
1,924
+508
+36% +$196K 0.03% 613
2023
Q2 		$542K Buy
1,416
+145
+11% +$51.8K 0.03% 612
2023
Q1 		$440K Sell
1,271
-79
-6% -$23.1K 0.03% 625
2022
Q4 		$318K Buy
1,350
+485
+56% +$115K 0.02% 669
2022
Q3 		$213K Buy
865
+116
+15% +$35.3K 0.03% 564
2022
Q2 		$226K Sell
749
-860
-53% -$280K 0.03% 537
2022
Q1 		$661K Buy
1,609
+981
+156% +$384K 0.1% 248
2021
Q4 		$295K Sell
628
-815
-56% -$351K 0.05% 410
2021
Q3 		$613K Buy
1,443
+13
+0.9% +$5.48K 0.68% 22
2021
Q2 		$514K Hold
1,430
– – 0.58% 49
2021
Q1 		$403K Sell
1,430
-539
-27% -$154K 0.44% 96
2020
Q4 		$558K Hold
1,969
– – 0.43% 52
2020
Q3 		$541K Sell
1,969
-519
-21% -$137K 0.36% 90
2020
Q2 		$565K Sell
2,488
-1,516
-38% -$298K 0.56% 6
2020
Q1 		$610K Sell
4,004
-447
-10% -$68.8K 0.38% 77
2019
Q4 		$669K Hold
4,451
– – 0.42% 37
2019
Q3 		$631K Sell
4,451
-290
-6% -$39.9K 0.43% 30
2019
Q2 		$593K Buy
4,741
+2,678
+130% +$316K 0.35% 63
2019
Q1 		$227K Sell
2,063
-448
-18% -$46.6K 0.15% 323
2018
Q4 		$246K Buy
+2,511
New +$272K 0.2% 268

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quantinno Capital Management's WST Position: Q2 2026 in Review

Quantinno Capital Management increased its West Pharmaceutical (WST) stake by 91% in Q2 2026, buying an estimated $44.8M and bringing the position to 308,116 shares worth $111M. The position accounts for 0.13% of the portfolio, ranked #137.

Quantinno Capital Management first reported a position in WST in Q4 2018 and has held it in 31 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Quantinno Capital Management held 308,116 shares of West Pharmaceutical worth $111M as of Q2 2026.
  • Quantinno Capital Management bought 146,638 West Pharmaceutical shares in Q2 2026, an estimated $44.8M.
  • West Pharmaceutical made up 0.13% of Quantinno Capital Management's portfolio in Q2 2026, its #137 holding.
  • Quantinno Capital Management first reported a position in West Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.